A Translational Study for Prediction of Biomarkers and Identification of Phenotype and Endotype of COPD and Early COPD Outcomes in Chinese Population

RecruitingOBSERVATIONAL
Enrollment

850

Participants

Timeline

Start Date

June 5, 2024

Primary Completion Date

July 7, 2027

Study Completion Date

July 7, 2027

Conditions
COPD
Trial Locations (12)

Unknown

NOT_YET_RECRUITING

Research Site, Beijing

NOT_YET_RECRUITING

Research Site, Changsha

NOT_YET_RECRUITING

Research Site, Chengdu

RECRUITING

Research Site, Guangzhou

NOT_YET_RECRUITING

Research Site, Hefei

NOT_YET_RECRUITING

Research Site, Nanjing

NOT_YET_RECRUITING

Research Site, Nanning

NOT_YET_RECRUITING

Research Site, Shanghai

NOT_YET_RECRUITING

Research Site, Shenyang

NOT_YET_RECRUITING

Research Site, Wuhan

NOT_YET_RECRUITING

Research Site, Xuzhou

NOT_YET_RECRUITING

Research Site, Zhengzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY